R. Raymond

发表

Standardized Mixed-Meal Tolerance and Arginine Stimulation Tests Provide Reproducible and Complementary Measures of β-Cell Function: Results From the Foundation for the National Institutes of Health Biomarkers Consortium Investigative Series

R. Bergman, C. Cobelli, C. Dalla Man, 2016, Diabetes Care.

Mixed Meal and Intravenous L-Arginine Tests Both Stimulate Incretin Release Across Glucose Tolerance in Man: Lack of Correlation with β Cell Function.

C. Cobelli, M. Staten, R. Robertson, 2018, Metabolic syndrome and related disorders.

Outpatient versus inpatient mixed meal tolerance and arginine stimulation testing yields comparable measures of variability for assessment of beta cell function

C. Cobelli, M. Staten, R. Robertson, 2018, Contemporary clinical trials communications.

Pharmacokinetics of Single-Dose Oral Stavudine in Subjects with Renal Impairment and in Subjects Requiring Hemodialysis

D. Grasela, S. Haworth, R. Stoltz, 2000, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics and safety of a single dose of stavudine (d4T) in patients with severe hepatic impairment

D. Grasela, B. Petty, B. Christofalo, 1997, Antimicrobial agents and chemotherapy.

Comparison of Pharmacokinetics of Lanoteplase and Alteplase During Acute Myocardial Infarction

J. Kostis, C. Pepine, U. Thadani, 2002, Clinical pharmacokinetics.

Modeling and Simulation of Abatacept Exposure and Interleukin‐6 Response in Support of Recommended Doses for Rheumatoid Arthritis 1

D. Mould, M. Pfister, A. Roy, 2007 .

Doses for Rheumatoid Arthritis Modeling and Simulation of Abatacept Exposure and Interleukin-6 Response in Support of

D. Mould, M. Pfister, A. Roy, 2007 .

Pharmacokinetics and Pharmacodynamics of Irbesartan in Patients with Hepatic Cirrhosis

K. Lasseter, N. Ford, R. Raymond, 1998, Journal of clinical pharmacology.

The effects of age and gender on the pharmacokinetics and pharmacodynamics in healthy subjects of the plasminogen activator, lanoteplase.

D. Boulton, W. Shyu, B. Stouffer, 2011, British journal of clinical pharmacology.

Vaccination response to tetanus toxoid and 23-valent pneumococcal vaccines following administration of a single dose of abatacept: a randomized, open-label, parallel group study in healthy subjects

L. Tay, G. Vratsanos, R. Raymond, 2007, Arthritis research & therapy.

Modeling and simulation of abatacept exposure and interleukin-6 response in support of recommended doses for rheumatoid arthritis.

D. Mould, M. Pfister, A. Roy, 2007, Journal of clinical pharmacology.

The effect of sorivudine on dihydropyrimidine dehydrogenase activity in patients with acute herpes zoster

R. Diasio, S. Tyring, Patricia C. Lee, 1997, Clinical pharmacology and therapeutics.

Effect of Hydrochlorothiazide on the Pharmacokinetics and Pharmacodynamics of the Angiotensin II Blocker Irbesartan

K. Lasseter, N. Ford, R. Raymond, 1997 .

Pharmacokinetic and Pharmacodynamic Evaluation During Coadministration of Nefazodone and Propranolol in Healthy Men

P. Marathe, D. Salazar, R. Raymond, 1995, Journal of clinical pharmacology.

Effect of Food on the Bioavailability of Stavudine in Subjects with Human Immunodeficiency Virus Infection

S. Kaul, C. MacLeod, B. Christofalo, 1998, Antimicrobial Agents and Chemotherapy.

Elimination of mouse allergens in the working environment: assessment of individually ventilated cage systems and ventilated cabinets in the containment of mouse allergens.

S. Fisher, S. Gordon, R. Raymond, 2001, The Journal of allergy and clinical immunology.

Single‐Dose and Steady‐State Pharmacokinetics of Fosinopril and Fosinoprilat in Patients with Hepatic Impairment

K. Lasseter, J. Manning, N. Ford, 1995, Journal of clinical pharmacology.

Arginine is preferred to glucagon for stimulation testing of β-cell function.

P. Savage, G. Weir, R. Robertson, 2014, American journal of physiology. Endocrinology and metabolism.

Pharmacokinetic and Pharmacodynamic Evaluation of Warfarin and Nefazodone Coadministration in Healthy Subjects

P. Chaikin, R. Dockens, D. Salazar, 1995, Journal of clinical pharmacology.

Pharmacodynamics and Pharmacokinetics of Irbesartan in Patients With Mild to Moderate Hypertension

K. Lasseter, J. Manning, N. Ford, 1999, Journal of cardiovascular pharmacology and therapeutics.

Drug Development

Robert A. Smith, R. Raymond, Z. Ge, 2000, Humana Press.

R. Bergman, C. Cobelli, M. Staten, 2016, Diabetes Care.

The pharmacokinetics of pravastatin in patients on chronic hemodialysis

D. Sica, N. Ford, T. Gehr, 1997, European Journal of Clinical Pharmacology.

Teplizumab: A Disease-Modifying Therapy for Type 1 Diabetes That Preserves β-Cell Function

S. Gitelman, K. Herold, P. Gottlieb, 2023, Diabetes care.

A preliminary pharmacokinetic and pharmacodynamic evaluation of the HIV protease inhibitor BMS-232632 in a protease inhibitor-naive HIV+ population

G. Drusano, A. Schuster, P. Piliero, 2000 .